Text of section as amended by Acts 2019, 86th Leg., R.S., Ch. 1166 (H.B. 3284), Sec. 9

For text of section as amended by Acts 2019, 86th Leg., R.S., Ch. 1105 (H.B. 2174), Sec. 15, see other Sec. 565.003.

Unless compliance would violate the pharmacy or drug statutes or rules in the state in which the pharmacy is located, the board may discipline an applicant for or the holder of a nonresident pharmacy license if the board finds that the applicant or license holder has failed to comply with:

1. (1) Subchapter C, Chapter 481, Health and Safety Code;

2. (2) Texas substitution requirements regarding:

   1. (A) the practitioner's directions concerning generic substitution;
   2. (B) the patient's right to refuse generic substitution; or
   3. (C) notification to the patient of the patient's right to refuse substitution;
3. (3) any board rule relating to providing drug information to the patient or the patient's agent in written form or by telephone; or
4. (4) any board rule adopted under Section 554.051(a) and determined by the board to be applicable under Section 554.051(b).

Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.

Acts 2005, 79th Leg., Ch. 1345 (S.B. 410), Sec. 45, eff. September 1, 2005.

Acts 2013, 83rd Leg., R.S., Ch. 608 (S.B. 1100), Sec. 7, eff. September 1, 2013.

Acts 2019, 86th Leg., R.S., Ch. 1166 (H.B. 3284), Sec. 9, eff. September 1, 2019.